1–4 of 4 results for Thomas A. Ciulla
“Real World” U.S. Outcomes of Anti-VEGF Therapy in Neovascular AMD: Risk of Vision Loss is Greatest in Patients with Better Baseline Visual Acuity
Thomas A. Ciulla, MD, MBA, FASRS
Annual Meeting Talks
2016
Real-world U.S. outcomes of anti-VEGF therapy in diabetic macular edema
Updates from the Field
2017
Idiopathic Juxtafoveal Telangectasia Type 1
Retina Image Bank: Images of the Week
2015
RAP Lesions
2014